S. Weinrib

Exceeding ADA Standards Among Uninsured Adults with Diabetes in Western North Carolina

Julie Hani, S. Weinrib, Steven Patch, 2021, ADCES in Practice.

The effect of addition of liraglutide to high‐dose intensive insulin therapy: a randomized prospective trial

W. Lane, S. Weinrib, J. Rappaport, 2014, Diabetes, obesity & metabolism.

Successful management of differentiated thyroid cancer in a community-based endocrine practice.

W. Lane, S. Weinrib, J. Rappaport, 2012, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

A prospective trial of U500 insulin delivered by Omnipod in patients with type 2 diabetes mellitus and severe insulin resistance.

W. Lane, S. Weinrib, J. Rappaport, 2010, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

The effect of long-term use of U-500 insulin via continuous subcutaneous infusion on durability of glycemic control and weight in obese, insulin-resistant patients with type 2 diabetes.

W. Lane, R. Lane, S. Weinrib, 2013, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

The effect of liraglutide added to U-500 insulin in patients with type 2 diabetes and high insulin requirements.

W. Lane, S. Weinrib, J. Rappaport, 2011, Diabetes technology & therapeutics.

Basal Insulin degludec and GLycemic control ComparEd to Aspart via insulin Pump in type 1 diabetes (BIGLEAP): a single-center, open-label, randomized, crossover trial.

W. Lane, S. Weinrib, Ryan T. Jarrett, 2021, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

The effect of addition of liraglutide to high‐dose intensive insulin therapy: a randomized prospective trial

S. Weinrib, J. Rappaport, C. Hale, 2014, Diabetes, obesity & metabolism.